4CU1 image
Deposition Date 2014-03-15
Release Date 2014-05-07
Last Version Date 2024-10-16
Entry Detail
PDB ID:
4CU1
Keywords:
Title:
Structure of bovine endothelial nitric oxide synthase heme domain in complex with 6-[(2S)-3-amino-2-{5-[2-(6-amino-4-methylpyridin-2-yl)ethyl]pyridin-3-yl}propyl]-4-methylpyridin-2-amine
Biological Source:
Source Organism:
BOS TAURUS (Taxon ID: 9913)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.89 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:NITRIC OXIDE SYNTHASE, ENDOTHELIAL
Gene (Uniprot):NOS3
Chain IDs:A
Chain Length:443
Number of Molecules:1
Biological Source:BOS TAURUS
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:NITRIC OXIDE SYNTHASE, ENDOTHELIAL
Gene (Uniprot):NOS3
Chain IDs:B
Chain Length:443
Number of Molecules:1
Biological Source:BOS TAURUS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CAS A CYS S-(DIMETHYLARSENIC)CYSTEINE
Primary Citation
Nitric Oxide Synthase Inhibitors that Interact with Both a Heme Propionate and Tetrahydrobiopterin Show High Isoform Selectivity.
J.Med.Chem. 57 4382 ? (2014)
PMID: 24758147 DOI: 10.1021/JM5004182

Abstact

Overproduction of NO by nNOS is implicated in the pathogenesis of diverse neuronal disorders. Since NO signaling is involved in diverse physiological functions, selective inhibition of nNOS over other isoforms is essential to minimize side effects. A series of α-amino functionalized aminopyridine derivatives (3-8) were designed to probe the structure-activity relationship between ligand, heme propionate, and H4B. Compound 8R was identified as the most potent and selective molecule of this study, exhibiting a Ki of 24 nM for nNOS, with 273-fold and 2822-fold selectivity against iNOS and eNOS, respectively. Although crystal structures of 8R complexed with nNOS and eNOS revealed a similar binding mode, the selectivity stems from the distinct electrostatic environments in two isoforms that result in much lower inhibitor binding free energy in nNOS than in eNOS. These findings provide a basis for further development of simple, but even more selective and potent, nNOS inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures